Envision Report

Published January 10, 2018

Stem Cell Therapeutics Market – Size, Outlook, Trends and Forecasts (2018 – 2024)

Request Free Sample Report!

Stem cell therapy is the use of stem cells to prevent diseases like bone marrow transplantation. Stem cells are unspecialized cells that can develop into various types of cells over time.

Stem Cell Therapeutic Market share:

The stem cell therapeutic market is segmented by treatment and geography. On basics of treatment, the largest share is in North America because of the demand for organs has been increasing, and organ transplantation is majorly driving the market share.

Stem Cell Therapeutic Market size:

Stem Cells Market is accounted for USD 14.1 billion in 2017 and expected to grow at a CAGR of 13% to reach USD 15.62 billion by 2024.

North America has the highest market for stem cell therapeutic market because of the increasing demand for organ donors, development of regenerative medicine and research on stem cell therapies are raising the demand for the market. During the forecast period, Asia-Pacific and Europe are going to have the quick growth in the market.

Stem Cell Therapeutic Market growth:

The market for stem cells therapeutic is driven by factors such as development in organ transplantations, regenerative medicine, increase in demand for organs, development of drugs and reimbursement policies increasing the growth of the stem cell therapeutic market.

Stem Cell Therapeutic Market Industrial Analysis:

Stem Cell Therapeutic Market is segmented on the basis of treatment, and geography. In this categorization, the growth of the market is driven by treatment segment classified by syngeneic stem therapy; allogeneic stem therapy, autologous stem therapy. Among other treatments, allogeneic stem therapy is the fastest growing stem cell therapeutic market.

Stem Cell Therapeutic Market Outlook:

Stem cell therapeutic is used to develop new methods for treating diseases such as dementia, organ transplantation, bone marrow treatments, cancer cells, tissues engineering and neural developments for neurological disorders further increased the demand for stem cells therapeutic and its predominant in North America especially the US.

Stem Cell Therapeutic Market Trends:

ViaCyte and BetaLogics have working on stem cell-derived therapy for diabetes. ViaCyte and Janssen Biotech, Inc. have merged into one firm in 2016.

Takara Bio USA Holdings, Inc. has completely acquired the WaferGen Bio-systems, Inc., WaferGen has become a subsidiary of TBUSH as of February 2017.

Stem Cell Therapeutic Market Research Report Includes:

  • An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
  • To have complete market analysis through industry value chain analysisPorter’s fivePESTLESWOT analysis, and Y-o-Y analysis.
  • Regional and global diversity is analysed with the major countries and the unions.
  • Scrutinizing the revenue generation on YearOnYear
  • Identifying DROCin the current market and their impact in altering the market dynamics.
  • Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial analysis with major competitors.
  • Expertise investment opportunities by an analyst to the individual and organization to have a better foothold in the market.
  • Identify the latest developments, market shares and strategies that are employed by the major market players, such as:
  • Neuralstem, Inc.
  • NsGene
  • Osiris Therapeutics, Inc.
  • Geron Corporation
  • Aastrom Biosciences, Inc.

Chapter 1 Introduction

1.1 Executive Summary

1.2 Market Definition

1.3 Scope of the Study

Chapter 2 Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.3 Analytic Tools and Model

2.4 Economic Indicator

2.4.1 Base Year, Base Currency, Forecasting Period

2.5 Expert Validation

2.6 Study Timeline

Chapter 3 Market Analysis

3.1 Industry Value Chain Analysis

3.2 Porter’s Five Analysis

3.2.1 Bargaining Power of Buyers

3.2.2 Bargaining Power of Suppliers

3.2.3 Threats of Substitutes

3.2.4 Threats of New Entrants

3.2.5 Industry Rivalry

3.3 PESTLE Analysis

3.3.1 Political

3.3.2 Economical

3.3.3 Social

3.3.4 Technological

3.3.5 Legal

3.3.6 Environmental

3.4 SWOT Analysis

3.4.1 Strengths

3.4.2 Weakness

3.4.3 Opportunities

3.4.4 Threats

3.5 Y-O-Y Analyses

Chapter 4 Market Dynamics

4.1 DROC

4.1.1 Drivers

4.1.2 Restraints

4.1.3 Opportunities

4.1.4 Challenges

Chapter 5 Market Segmentation Analysis

Chapter 6 Market Segmentation by Treatment

6.1 Syngeneic Stem Cell Therapy

6.1.1 Neurology

6.1.2 Cardiology

6.1.3 Oncology

6.1.4 Diabetes

6.1.5 Hematology

6.2 Allogeneic Stem Cell Therapy

6.3 Autologous Stem Cell Therapy

Chapter 7 Market Segmentation by Geography

7.1 North America

7.1.1 Introduction

7.1.2 United States

7.1.3 Canada

7.1.4 Mexico

7.1.5 Others

7.2 Europe

7.2.1 Introduction

7.2.2 Spain

7.2.3 UK

7.2.4 France

7.2.5 Russia

7.2.6 Italy

7.2.7 Others

7.3 Asia Pacific

7.3.1 Introduction

7.3.2 China

7.3.3 India

7.3.4 Japan

7.3.5 Australia & New Zealand

7.3.6 Others

7.4 The Middle East and Africa

7.4.1 Introduction

7.4.2 South Africa

7.4.3 Middle East Countries

7.4.4 Others

7.5 South America

7.5.1 Introduction

7.5.2 Argentina

7.5.3 Brazil

7.5.5 Others

Chapter 8 Competitive Landscape

8.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements

8.2 Market Share Analysis

8.3 Strategies Adopted By Top Companies

Chapter 9 Company Profiles

9.1 Kite Pharma

9.1.1. Company Overview

9.1.2. Financial Performance

9.1.3. Product Benchmarking

9.1.4. Strategic Initiative

9.2 Stemcells, Inc.

9.3 Advanced Cell Technology

9.4 Neuralstem, Inc.

9.5 NsGene

9.6 Osiris Therapeutics, Inc.

9.7 Geron Corporation

9.8 Aastrom Biosciences, Inc.

9.9 Invitrogen

9.10 Novocell (ViaCyte, Inc.)

9.11 Cellular Engineering Technologies Inc.

9.12 CellGenix GmbH

9.13 Athersys

9.14 Cytori Therapeutics, Inc.

9.15 Takara Bio USA Holdings, Inc.

Chapter 10 Market Estimates and Forecasting

10.1 Market Estimates and Forecasting 2018-2024(USD Million)

10.1.1 Market Estimates and Forecasting by Services 2018-2024 (USD Million)

10.1.2 Market Estimates and Forecasting by Geography 2018-2024 (USD Million)

Chapter 11 Market Insights

11.1 Insights of Industry Experts

11.2 Analyst Opinion (Market Understanding)

11.3 Investment Opportunities

Chapter 12 Appendix

12.1 List of Tables

12.2 List of Figures

  • Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
  • Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
  • The Regional and Global Variety is taken care of in the report.
  • Year on Year basis generation of revenue is studied.
  • Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
  • The overview and the sustainability of the market are analyzed through SWOT.
  • DROC is recognized in the current market scenario and see how its effect on market dynamics.
  • The segment-level analysis in terms of type and technology.
  • The value chain analysis, value that's created and captured by a company is the profit margin.Value
  • Created and Captured – Cost of Creating that Value = Margin
  • An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
  • Basis on the depth of the study we approach using analytical tools
  • Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.


©2018 - Envision Inteligence | All Rights Reserved.